1033 related articles for article (PubMed ID: 29311644)
41. Inflammatory bowel disease: between genetics and microbiota.
Younis N; Zarif R; Mahfouz R
Mol Biol Rep; 2020 Apr; 47(4):3053-3063. PubMed ID: 32086718
[TBL] [Abstract][Full Text] [Related]
42. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
Lopetuso LR; Petito V; Graziani C; Schiavoni E; Paroni Sterbini F; Poscia A; Gaetani E; Franceschi F; Cammarota G; Sanguinetti M; Masucci L; Scaldaferri F; Gasbarrini A
Dig Dis; 2018; 36(1):56-65. PubMed ID: 28683448
[TBL] [Abstract][Full Text] [Related]
43. Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn's remission patients despite temporal variations in microbial taxa, genomes, and proteomes.
Blakeley-Ruiz JA; Erickson AR; Cantarel BL; Xiong W; Adams R; Jansson JK; Fraser CM; Hettich RL
Microbiome; 2019 Feb; 7(1):18. PubMed ID: 30744677
[TBL] [Abstract][Full Text] [Related]
44. The evidence for fungus in Crohn's disease pathogenesis.
Miyoshi J; Sofia MA; Pierre JF
Clin J Gastroenterol; 2018 Dec; 11(6):449-456. PubMed ID: 30027368
[TBL] [Abstract][Full Text] [Related]
45. Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome.
Li E; Zhang Y; Tian X; Wang X; Gathungu G; Wolber A; Shiekh SS; Sartor RB; Davidson NO; Ciorba MA; Zhu W; Nelson LM; Robertson CE; Frank DN
PLoS One; 2019; 14(2):e0213108. PubMed ID: 30818349
[TBL] [Abstract][Full Text] [Related]
46. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
Teofani A; Marafini I; Laudisi F; Pietrucci D; Salvatori S; Unida V; Biocca S; Monteleone G; Desideri A
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057440
[TBL] [Abstract][Full Text] [Related]
47. Gut mycobiome: The probable determinative role of fungi in IBD patients.
Beheshti-Maal A; Shahrokh S; Ansari S; Mirsamadi ES; Yadegar A; Mirjalali H; Zali MR
Mycoses; 2021 May; 64(5):468-476. PubMed ID: 33421192
[TBL] [Abstract][Full Text] [Related]
48. The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis.
Prosberg M; Bendtsen F; Vind I; Petersen AM; Gluud LL
Scand J Gastroenterol; 2016 Dec; 51(12):1407-1415. PubMed ID: 27687331
[TBL] [Abstract][Full Text] [Related]
49. Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease.
Ungaro F; Massimino L; Furfaro F; Rimoldi V; Peyrin-Biroulet L; D'Alessio S; Danese S
Gut Microbes; 2019; 10(2):149-158. PubMed ID: 30252582
[TBL] [Abstract][Full Text] [Related]
50. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis.
Song H; Yoo Y; Hwang J; Na YC; Kim HS
J Allergy Clin Immunol; 2016 Mar; 137(3):852-60. PubMed ID: 26431583
[TBL] [Abstract][Full Text] [Related]
51. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
Malham M; Lilje B; Houen G; Winther K; Andersen PS; Jakobsen C
Scand J Gastroenterol; 2019 Aug; 54(8):969-975. PubMed ID: 31329473
[No Abstract] [Full Text] [Related]
52. Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease.
Fornelos N; Franzosa EA; Bishai J; Annand JW; Oka A; Lloyd-Price J; Arthur TD; Garner A; Avila-Pacheco J; Haiser HJ; Tolonen AC; Porter JA; Clish CB; Sartor RB; Huttenhower C; Vlamakis H; Xavier RJ
Nat Microbiol; 2020 Mar; 5(3):486-497. PubMed ID: 31959971
[TBL] [Abstract][Full Text] [Related]
53. Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients.
Brand EC; Klaassen MAY; Gacesa R; Vich Vila A; Ghosh H; de Zoete MR; Boomsma DI; Hoentjen F; Horjus Talabur Horje CS; van de Meeberg PC; Willemsen G; Fu J; Wijmenga C; van Wijk F; Zhernakova A; Oldenburg B; Weersma RK;
Gastroenterology; 2021 May; 160(6):1970-1985. PubMed ID: 33476671
[TBL] [Abstract][Full Text] [Related]
54. Location-specific signatures of Crohn's disease at a multi-omics scale.
Gonzalez CG; Mills RH; Zhu Q; Sauceda C; Knight R; Dulai PS; Gonzalez DJ
Microbiome; 2022 Aug; 10(1):133. PubMed ID: 35999575
[TBL] [Abstract][Full Text] [Related]
55. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.
Lloyd-Price J; Arze C; Ananthakrishnan AN; Schirmer M; Avila-Pacheco J; Poon TW; Andrews E; Ajami NJ; Bonham KS; Brislawn CJ; Casero D; Courtney H; Gonzalez A; Graeber TG; Hall AB; Lake K; Landers CJ; Mallick H; Plichta DR; Prasad M; Rahnavard G; Sauk J; Shungin D; Vázquez-Baeza Y; White RA; ; Braun J; Denson LA; Jansson JK; Knight R; Kugathasan S; McGovern DPB; Petrosino JF; Stappenbeck TS; Winter HS; Clish CB; Franzosa EA; Vlamakis H; Xavier RJ; Huttenhower C
Nature; 2019 May; 569(7758):655-662. PubMed ID: 31142855
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
Qiao YQ; Cai CW; Ran ZH
J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
[TBL] [Abstract][Full Text] [Related]
57. Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.
Klaassen MAY; Imhann F; Collij V; Fu J; Wijmenga C; Zhernakova A; Dijkstra G; Festen EAM; Gacesa R; Vich Vila A; Weersma RK
J Crohns Colitis; 2019 Oct; 13(11):1439-1449. PubMed ID: 31066440
[TBL] [Abstract][Full Text] [Related]
58. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD.
Lee T; Clavel T; Smirnov K; Schmidt A; Lagkouvardos I; Walker A; Lucio M; Michalke B; Schmitt-Kopplin P; Fedorak R; Haller D
Gut; 2017 May; 66(5):863-871. PubMed ID: 26848182
[TBL] [Abstract][Full Text] [Related]
59. Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
Chu ND; Crothers JW; Nguyen LTT; Kearney SM; Smith MB; Kassam Z; Collins C; Xavier R; Moses PL; Alm EJ
mBio; 2021 Aug; 12(4):e0097521. PubMed ID: 34281401
[TBL] [Abstract][Full Text] [Related]
60. The Origin of Plasma-Derived Bacterial Extracellular Vesicles in Healthy Individuals and Patients with Inflammatory Bowel Disease: A Pilot Study.
Jones E; Stentz R; Telatin A; Savva GM; Booth C; Baker D; Rudder S; Knight SC; Noble A; Carding SR
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
